Generalizing the intention-to-treat effect of an active control against placebo from historical placebo-controlled trials to an active-controlled trial: A case study of the efficacy of daily oral TDF/FTC in the HPTN 084 study
In many clinical settings, an active-controlled trial design (e.g., a non-inferiority or superiority